Loading...

Loading...

FDA Approves Winrevair: Breakthrough in PAH Treatment
By MBN Staff - Wed, 03/27/2024 - 16:00
Merck's Winrevair targets PAH's root cause, offering hope beyond symptom management. FDA approval marks a milestone in cardiovascular care.

https://mexicobusiness.news/tag/merck
More Health
 Merck Plans Clinical Trials for Enhanced HPV Vaccine
By MBN Staff - Tue, 03/19/2024 - 17:31

Merck tests new HPV vaccines and dosing, aiming at reducing global HPV-related cancers.

Primary Care, Well-being in Focus: The Week in Health
By Sofía Garduño - Thu, 07/27/2023 - 10:00
This week, CONASAMA promoted self-care while PAHO highlighted the importance of primary care in achieving universal healthcare coverage.
Johnson & Johnson Becomes Most Valuable Pharma Brand of 2023
By Sofía Garduño - Thu, 07/20/2023 - 11:52
Brand Finance's healthcare report names Johnson & Johnson as the most valuable brand worldwide.
Merck Boosts Presence in Mexico with €20 Million Investment
By Sofía Garduño - Mon, 04/17/2023 - 13:57
The investment will aid in the expansion of Merck's production plant in Naucalpan, State of Mexico.
Collaboration, Digitization Crucial for Oncology Innovation
By Antonio Gozain - Thu, 09/01/2022 - 10:20
From regulatory obstacles to a fragmented healthcare system, Mexico faces several challenges to offer innovative cancer treatments.
Pharmacoeconomics: Tool for Innovation and Access
By Sofía Garduño - Wed, 08/31/2022 - 16:32
Healthcare providers are embracing pharmacoeconomics to make better decisions, but the field must also improve.

Bio Convention an Opportunity to Demonstrate Mexico’s Potential
By Victor Gabriel Sánchez - Wed, 06/29/2022 - 10:00
Ahead of the annual global bio convention, Victor Sanchez explains the opportunity for Mexico in this growing industry.
Roche’s New Cancer Immunotherapy Fails in first Late-Stage Trial
By Antonio Gozain - Thu, 03/31/2022 - 13:32
Roche said that tiragolumab, combined with its established cancer drug Tecentriq and chemotherapy, failed to reduce the rate of disease progression.
Mexico Negotiates with Merck, Pfizer for “COVID-19 Pills”
By Alfonso Núñez - Wed, 01/19/2022 - 10:41
After COFEPRIS approved the emergency use of molnupiravir and paxlovid, the government is negotiating with labs to distribute the medicines.